Web27 Sep 2024 · The company’s lead product candidate, topical roflumilast, has the potential to advance the standard of care for plaque psoriasis, atopic dermatitis, scalp psoriasis, and seborrheic dermatitis. For more information, visit www.arcutis.com or follow Arcutis on LinkedIn and Twitter. Forward-Looking Statements Web27 Feb 2024 · Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis (DERMIS-OLE) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST IN …
WebHow to use Roflumilast 0.3 % Topical Cream Read the Patient Information Leaflet if available from your pharmacist before you start using roflumilast and each time you get a … Web20 Sep 2024 · The authors concluded that topical roflumilast represents an effective topical therapy for use on all psoriasis-affected areas including body, face, and intertriginous … michael whittington santa clara county
Roflumilast Cream Significantly Benefits Psoriasis Severity, Itch in ...
Web25 Mar 2024 · Lebwohl and colleagues concluded roflumilast cream 0.3% showed statistically significant improvements in treated patients with psoriasis across all assessed endpoints of the DERMIS trials, while also showing favorable local tolerability—a key outcome for a potential once-daily topical agent. “The pooled results of the phase 3 … Web13 Oct 2024 · The once daily application of roflumilast cream also improved the quality of life (QOL) of patients in the DERMIS-1 (NCT04211363) and DERMIS-2 (NCT04211389) phase 3 pivotal studies in chronic plaque psoriasis, according to the press release. 1 These data were presented at the annual European Academy of Dermatology and Venereology … WebTopical roflumilast foam (ARQ-154) is a foam formulation of a highly potent and selective PDE4 inhibitor (roflumilast) which Arcutis is developing for the treatment of inflammatory dermatoses, particularly in hair-bearing areas of the body, such as the scalp. michael whittle